Status:
RECRUITING
Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders
Lead Sponsor:
University of Pennsylvania
Conditions:
Placenta Accreta Spectrum
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- A person with a uterus, age 18 or older
- Currently 16-36 weeks pregnant with an intrauterine gestation
- History of cesarean delivery AND placenta previa OR anterior low-lying placenta AND suspected of having PAS on prenatal imaging (ultrasound/MRI)
- Patients for whom the usual management would be cesarean-hysterectomy.
- Patient desires uterine preservation
- Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration.
Exclusion
- • Have a low antenatal suspicion for PAS based on imaging.
Key Trial Info
Start Date :
April 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06512181
Start Date
April 21 2025
End Date
December 31 2030
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104